In vitro culture systems of human myogenic cells contribute greatly to elucidation of the molecular mechanisms underlying terminal myogenic differentiation and symptoms of neuromuscular diseases. However, human myogenic cells have limited ability to proliferate in culture. We have established an improved immortalization protocol for human myogenic cells derived from healthy and diseased muscles; constitutive expression of mutated cyclin-dependent kinase 4, cyclin D1 and telomerase immortalized human myogenic cells. Normal diploid chromosomes were preserved after immortalization. The immortalized human myogenic cells divided as rapidly as primary human myogenic cells during the early passages, and underwent myogenic, osteogenic and adipogenic differentiation under appropriate culture conditions. The immortalized cells contributed to muscle differentiation upon xenotransplantation to immunodeficient mice under conditions of regeneration following muscle injury. We also succeeded in immortalizing cryopreserved human myogenic cells derived from Leigh disease patients following primary culture. Forced expression of the three genes shortened their cell cycle to o30 h, which is similar to the doubling time of primary cultured human myogenic cells during early passages. The immortalization protocol described here allowed human myogenic cells to recapture high proliferation activity without compromising their differentiation potential and normal diploidy.
INTRODUCTION
Skeletal muscle stem cells of adult muscle are known as muscle satellite cells because they are located adjacent to the plasma membrane of myofibers beneath the basement membrane. The postnatal growth, repair and maintenance of skeletal muscle rely on muscle satellite cells that proliferate and then fuse together to form myotubes. Actually, phenotypic analysis of Pax7-deficient mice strongly suggests that the loss of satellite cells abolishes the regenerative capacity of skeletal muscle. 1, 2 The decrease of regenerative capacity of muscle results in muscle dysfunction during both normal aging and progression of muscle-regenerative diseases, such as muscular dystrophies.
Most of the data on the regulation of proliferation and differentiation of muscle satellite cells and their descendant progenitor cells have been obtained from primary cultured chick myogenic cells or mouse myogenic cell lines. [3] [4] [5] However, several previous studies strongly suggest that animal myogenic cells do not always use the same pathways to control proliferation and differentiation as human myogenic cells. 6, 7 Although animal cell models certainly contribute to understanding the mechanisms of human myogenesis and muscle diseases, the precise and detailed analysis of human myogenic cells is essential for fundamental and therapeutic investigation. Unfortunately, progressively compromised differentiation potential, as well as proliferation potential, is seen in cultured human myogenic cells. 8, 9 The limited proliferation capacity and progressive alterations of characteristics of human myogenic cells do not allow us to carry out both qualitative and quantitative analyses with high reproducibility.
Previous attempts have been made to extend the replication capacity of human myogenic cells using viral oncogenes such as simian virus 40 large T antigen and/or the reverse transcriptase component of human telomerase (hTERT). 10 However, no reliable model of immortalized human myogenic cells that exhibit differentiation potential had been established until our previous study. 9 We previously reported that constitutive expression of hTERT and human papillomavirus type 16 gene E7 immortalizes a primary normal human myogenic cell clone designated Hu5. The immortalized human myogenic cell clone Hu5/ E18 largely preserves the myogenic phenotype represented by parental Hu5 cells, but their doubling time is approximately 12 h longer than that of primary human myogenic cells during early passages. E7 is an oncogene that inactivates the retinoblastoma protein pRb, 11 and does not transform human myogenic cells. However, we cannot exclude a possibility that E7 also affects other biological functions, including transformation-related pathways.
Cellular stress activates a pathway of the cyclin-dependent kinase inhibitor p16 INK4a , resulting in premature cell cycle arrest before telomere attrition, 12 probably due to the activation of Rb. The forced expression of wild-type cyclin-dependent kinase 4 (CDK4) enabled hTERT to immortalize primary human myogenic cells, presumably because cdk4 sequesters the increased p16 exclusively when stimulated with dexamethasone and hepatocyte growth factor. 13 In addition, the co-expression of hTERT and Bmi-1, which suppresses p16 INK4a expression, failed to immortalize human myogenic cells. 9, 14 These results indicate that combining the expression of hTERT and sequestration of p16 INK4a is insufficient to immortalize human myogenic cells, or that the p16 INK4a pathway is incompletely suppressed under these conditions.
In the present study, to block the p16 INK4a -Rb pathway and enhance cell cycle progression, without the use of oncoprotein E7, expressions of hTERT and both mutant CDK4 (CDK4R24C) and cyclin D1 were induced in human myogenic cells. Combined expression of the three genes efficiently immortalized normal human myogenic cells. The immortalized cells still retained multipotentiality and a doubling time similar to that of primary cultured human myogenic cells. The established normal human myogenic cell clones in the present study are the human equivalents of mouse cell lines such as C2 (ref.
3) and Ric10. 5, 15 In addition, we succeeded in immortalization of diseased muscle-derived primary human myogenic cells that showed the prolonged doubling time. The newly established method for immortalization of primary human myogenic cells will open new avenues for mechanistic and therapeutic research on human muscle diseases.
RESULTS
p16 INK4a -Rb pathway is activated upon growth arrest of primary cultured human myogenic cells Proliferation capacity of primary cultured human myogenic cells severely declined during serial passages under the present culture condition (Figure 1a) . The doubling time of the cells became longer as they were serially succeeded (Supplementary Figure 1) . Constant or high level expression of cyclin D1, CDK4, cyclin-dependent kinase inhibitor p21 cip1 and p53 was observed in primary human myogenic cells even upon growth arrest (Figure 1b) . In contrast, the amount of the cell cycle inhibitor p16 INK4a increased along with the culture period, whereas the amount of hyperphosphorylated form of Rb declined. The amount of another cell cycle-driving kinase CDK2 decreased following the disappearance of hyperphosphorylated form of Rb. The results indicate that the p16 INK4a -Rb pathway is activated before growth arrest of primary cultured human myogenic cells, suggesting that their cell cycle arrest is due to the activation of Rb. The disappearance of hyperphosphorylated Rb seems unlikely to depend on the downregulation of either CDK2 or CDK4 that are kinases relevant for phosphorylation of Rb.
E7 promotes nuclear progression in terminally differentiated myotubes The primary human myogenic progenitor cell clone Hu5 was obtained from a healthy muscle of a non-dystrophic woman. 4 Hu5 cells have limited ability to proliferate but can be immortalized by constitutive expression of both telomerase and the E7 gene from human papillomavirus type 16. 9 E7 inactivates Rb but is also suspected to affect other cellular functions. To determine whether constitutive expression of E7 transforms human myogenic cells, the Hu5-derived myogenic cell clone Hu5/E18 (ref. 9) , immortalized by constitutive expression of both hTERT and E7, was transplanted into cardiotoxin-injected TA muscles of immunodeficient NOD/Scid mice (Figures 2a and b) . Before transplantation, E18 cells were infected with a lentivirus vector encoding green fluorescent protein Venus (kindly provided by Dr Miyoshi). Transplanted cells were identified by the fluorescence of Venus and antibodies specific for green fluorescent protein. Transplanted E18 cells (2.5Â10 6 cells per TA) gave rise to myofibers labeled with green fluorescence. No tumor was formed in the transplanted TA muscles. Soft agar assays also showed that E18 was unable to grow in an anchorage-independent way (Supplementary Figure 2) . The results indicate that E18 cells did not show any oncogenic potential either in vivo or in vitro.
In the next experiment, effects of the immortalization on cell cycle exit during terminal muscle differentiation were analyzed in vitro. E18 cells undergo myogenic terminal differentiation under the myogenic differentiation-inducing condition. 9 Primary cultured human myogenic progenitor cells exited the cell cycle and gave rise to terminally differentiated myotubes (Figures 2c-f) . In contrast, the nuclei of E18 myotubes synthesized DNA and also contained the proliferation marker protein Ki-67, although neither nuclear nor cellular division was observed in the myotubes (Figures 2g-j) . The results suggest that E7 promotes nuclear progression in terminally differentiated myotubes that have lost mitogenic potential. In addition, the doubling time of the Hu5-derived immortalized cells is approximately 35 h, 9 whereas primary cultured human myogenic cells divided at 20-29 h intervals (Supplementary Figure 3) . Taken together with the results here, the expression of hTERT and E7 immortalizes human myogenic cells without the loss of their differentiation potential but also affects their cell cycle properties during the terminal myogenic differentiation.
Cell cycle drivers efficiently immortalize primary cultured human myogenic cells E7 promotes nuclear progression in myotubes, perhaps, because it accelerates the degradation of Rb family proteins including Rb, p130 and p107. To inactivate Rb directly and avoid unusual promotion of nuclear progression in myotubes, Hu5 cells were infected with recombinant lentiviruses encoding hTERT, CDK4R24C and cyclin D1. The single amino acid change in CDK4 prevented a cyclin-dependent kinase inhibitor, p16 INK4a , from inhibiting kinase activity of CDK4. Forced expression of CDK4R24C, cyclin D1 and hTERT efficiently expanded the lifespan of Hu5 cells and virtually immortalized Hu5 cells. Immortalized Hu5 derivatives expressing CDK4R24C and cyclin D1 under control of the human cytomegalovirus immediate early promoter were designated as Hu5/KD, whereas the cells expressing them under the control of the Tet-Off system were designated as Hu5/TKD. The pooled populations, Hu5/KD and Hu5/TKD, and their derivative clones, KD3 and TKD1, divided rapidly at a similar interval as primary myogenic cells did (Figures  3a-d) . The expression of hTERT, CDK4R24C and cyclin D1 culminated in continuous cell proliferation for more than 200 population doublings (Figures 3e and f) . In contrast to E7, the cell cycle drivers did not promote nuclear progression in terminally differentiated myotubes nor interfere with the cell cycle exit of myogenic progenitor cells under the differentiation-inducing condition (Figures 3g-k;  Supplementary Figure 4) . Hu5 derivatives transduced with recombinant lentiviruses encoding hTERT and CDK4R24C proliferated continuously but relatively slowly. Forced expression of hTERT and cyclin D1 did not immortalize Hu5 cells. We therefore concluded that the combined expression of the three genes immortalized human myogenic progenitor cells, resulting in restoration of their growth properties similar to that of primary cultured human myogenic cells.
Immortalized human myogenic cells preserve myogenic phenotype
To determine the karyotype of immortalized human myogenic cells at passages 18-30, about 22-32 metaphase spreads of each cell type were analyzed. The results show the cells maintained a normal 46XX diploid karyotype in both the immortalized populations and the immortalized clones (Figure 4) .
High-level expression of CDK4 and cyclin D1 was observed in the immortalized cells (Figure 5a ). pRb was highly phosphorylated under the growing condition. The cell cycle inhibitor p16 INK4a remained at an extremely high level in the immortalized cells (Figure 5a ). However, hypophosphorylated form of pRb was accumulated under the myogenic differentiation-inducing condition. Both the immortalized populations and the immortalized clones fused together and gave rise to myotubes. In addition, MyoD was highly expressed in the nuclei of myotubes (Figures 5b and c) . The results here indicate that the immortalized clones KD3 and TKD1 preserved the myogenic phenotype represented by the previously immortalized Hu5 derivatives. 9 Immortalized human myogenic cells retain differentiation potential both in vivo and in vitro The cells immortalized by the forced expression of hTERT and E7 preserved the phenotypic characteristics of their parental Hu5 cells, including multipotentiality; one of the E7-expressing immortalized Hu5 cell clones, E18, retained the ability to undergo myogenic, osteogenic and adipogenic terminal differentiation. 7, 9 The CDK4R24C and cyclin D1-expressing immortalized clones, KD3 and TKD1, also underwent myogenic, osteogenic and adipogenic terminal differentiation under the appropriate culture conditions (Figures 6a-c and f-h), although adipogenic differentiation was induced at relatively low efficiency.
To determine whether the immortalized human myogenic cells contributed to muscle regeneration in vivo, KD3 and TKD1 cells were transplanted into cardiotoxin-injected TA muscles of immunodeficient NOD/Scid mice. Before transplantation, KD3 and TKD1 cells were infected with a lentivirus vector encoding green fluorescent protein Venus. (c-j) Primary cultured human myogenic cell Hu26 (c-f) and immortalized human myogenic cell clone E18 expressing telomerase and E7 (g-j) were cultured for up to 78 h in primary cultured myocyte differentiation medium. For the detection of DNA synthesis, cells were incubated with 10 mM 5-bromo-2¢-deoxyuridine for the last 6 h of a 78-h differentiation culture (c, d, g, h). Phase contrast images (c, e, g, i) and immunofluorescence analysis with anti-5-bromo-2¢-deoxyuridine antibody (red in d, h), or Ki67 (red in f, j) of the same fields are shown in each row. Nuclei were stained with 2,4-diamidino-2-phenylindole dihydrochloride n-hydrate (blue in d, f, h, j). Scale bars, 50 mm.
± 9.1% of total TA myofibers, respectively) (Figures 6d and i).
The relatively large s.d. in the present results was because of the low numbers of positive myofibers in the two specimens, probably due to leakage of the transferred cells to the injected TA muscle. Venuspositive myofibers were regenerated myofibers because they contained central nuclei (Figures 6e and j) . No tumor was observed in the transplanted TA muscles. In vitro soft agar assay also showed that KD3 cells did not grow in an anchorage-independent way (Supplementary Figure 2) . The results suggest that KD3 cells do not possess oncogenic potential. The ability of the immortalized human myogenic cells to regenerate muscle in vivo indicates that the immortalized cells established here represent a good model cell system for the fundamental and therapeutic study of human muscle development and disease.
Human myogenic cells recaptured proliferation capacity in cellcycle driver-dependent manner Both CDK4R24C and cyclin D1 were expressed under the control of the Tet-Off system in TKD1 cells. To determine the role of cell cycle drivers in the continuous proliferation of human myogenic cells, the expressions of CDK4R24C and cyclin D1 were suppressed by administration of doxycycline. Expression levels of CDK4 and cyclin D1 in TKD1 cells markedly declined during 5 days of incubation with doxcycline ( Figure 7a ). Doxcycline itself impaired neither the protein levels of either CDK4 or cyclin D1 in KD3 cells (Supplementary Figure 5) nor their DNA synthesis (Figures 7b-g ). The number of proliferating TKD1 cells reduced following the decline in CDK4 and cyclin D1 proteins (Figures 7i, l) . The morphology of doxycycline-treated TKD1 cells also became more flattened like senescent cells, and the nuclei looked thin during the cessation of proliferation (Figures 7h, j, k, m) . In contrast, when doxycycline was removed from the culture, CDK4 and cyclin D1 were restored, and the proliferation capacity was completely recaptured by TKD1 cells (Figures 7a lane 4 and n-p) . The results suggest that the proliferation capacity of human myogenic cells expressing hTERT is fully dependent on CDK4R24C and cyclin D1, and that before cellular senescence accompanied by telomeric attrition, human myogenic cells are capable of recapturing proliferation capacity.
Cryopreserved human myogenic cells derived from a disease muscle recapture proliferating activity by immortalization Primary cultured human myogenic cells lose the ability to proliferate by degrees during culture in vitro. Cryopreserved primary cultured human myogenic cells obtained from Leigh disease muscle suffered from growth impairment accompanied by a prolonged cell cycle. One of the mortal cell clones from the primary cultured Leigh disease myogenic cells, HM2-5, which had a cell cycle of 73.5 h at passage 10 ( Figure 8a ), was infected with recombinant lentiviruses. Forced expression of hTERT, CDK4R24C and cyclin D1 had the cells dividing rapidly with a doubling time of 27.7 h (HM255, Figure 8b) . A combination of hTERT and E7 also rescued the cells from growth impairment, but their doubling time (36.6 h) (HM253, Figure 8c ) was longer than that of the clone immortalized by hTERT, CDK4R24C and cyclin D1. Both immortalized multiclonal populations HM253 and HM255 retained the ability to undergo terminal myogenic, osteogenic and adipogenic differentiation (Figures 8d-i) . A cryopreserved mortal cell clone from muscle of another Leigh disease patient also recaptured its proliferation capacity and multipotentiality through immortalization by the combined expression of hTERT, CDK4R24C and cyclin D1 (Supplementary Figure 6) . These results suggest that transduction of the three genes renders growth-impaired human myogenic cells proliferative and immortalized without loss of their differentiation potentialities. 
DISCUSSION
Sarcopenia is an age-related loss of muscle mass leading to muscle weakness and atrophy. The slower regenerative capacity of aging muscle may be attributed to a decrease in the number and/or proliferation and differentiation capacities of muscle satellite cells. Actually, the number of satellite cells declines with age in humans. 16, 17 In addition, the proliferation potential of human muscle satellite cells is limited by cellular senescence induced by progressive telomere shortening. 16, 18 When the telomere length becomes less than about 5 kb, the Rb and p53 pathways are activated and culminate in irreversible growth arrest. 11, 19, 20 Cells also enter a state designated as stress or aberrant signal-induced senescence 18, 20 (STASIS) or stressinduced premature senescence 21 (SIPS) that closely resembles replicative senescence when subjected to sub-lethal stress or oncogenic signals. The major characteristics of cells undergoing STASIS/SIPS are similar to those of replicatively senescent cells: the Rb and/or p53 pathways are activated and the cells stop proliferation. STASIS/SIPS can be induced in a telomere-independent way in human epithelial cells 11 and even in human fibroblasts, 12 although acceleration of telomere shortening is associated with STASIS/SIPS. Under conventional culture conditions, many types of human cells are likely to undergo precocious growth arrest before replicative senescence induced by telomere shortening, 22 though some types of human cells appear to be immortalized by the expression of hTERT alone without transformation of cell properties. 11, 23, 24 In fact, our previous and present studies strongly suggest that both inactivation of the Rb pathway and restoration of telomerase activity are required for efficient immortalization of human myogenic cells ( Figure 9A ). The growth arrest of primary cultured human myogenic cells may be attributable to an inadequate cellular context including culture conditions that stimulate the stress signaling pathway. 25 Several previous studies emphasized that the age-related dysfunction of muscle is attributed to the age-related changes in environmental factors that attenuate the potential of muscle satellite cells. Transplantation of whole muscles between old and young rats shows that the regenerative capacity of aged muscle is enhanced when grafted into young muscle. 26 The decrease of circulating growth factors 27 and the number of motor units 28 are candidates for the responsible environmental factors or age-related changes in skeletal muscle. In addition, primary cultured human myogenic cells derived from skeletal muscles of aged persons (475 years old) show growth properties similar to those of the myogenic cells obtained from younger persons under the appropriate culture conditions (Supplementary Figure 3A ) (Hashimoto and Okamura, unpublished data). On the other hand, a previous study showed that myogenic cells from aged muscle demonstrated less ability to proliferate in primary cultures. 6 Given that myogenic cells derived from an aged human are fragile and likely to lose proliferation potential under inappropriate culture conditions, these different results under different culture conditions are plausible. Actually, we have found that the proliferation capacity of human and mouse primary myogenic cells maintained in a medium containing DMEM is higher than that of the cells maintained in a medium containing Ham's F10, even though an F10-based medium was used to isolate and culture primary myogenic cells in many studies. 6, 29 Muscle-degenerative diseases such as muscular dystrophies provoke extensive replication of human muscle satellite cells. 30 Satellite cells in regenerating muscles also suffer from cellular stresses including those induced by inflammatory cytokines. Therefore, precocious growth arrest, as well as the replicative senescence of satellite cells, is likely to cause the loss of muscle-regenerative capacity in muscle-degenerative diseases. Results obtained by previous and present studies indicate a possibility of a new therapeutic strategy for sarcopenia and muscular dystrophy that overcomes the precocious growth arrest triggered by the Rb pathway. Human myogenic cells are vulnerable to cellular stresses and more likely to undergo premature growth arrest than human foreskin fibroblasts because primary cultured human fibroblasts undergo precocious growth arrest/STASIS/SIPS exclusively when exposed to stress inducers such as H 2 O 2 and ultraviolet light. 21 From this point of view, the Rb pathway in human myogenic cells will be an attractive target of therapeutic intervention in muscle-degenerative diseases. The present study also shows that the total amount of pRb declined during growth arrest in primary human myogenic cells at later passages, immortalized human myogenic cells undergoing myogenesis and TKD1 cells stimulated with doxycycline. Therefore, we should consider both quantitative and qualitative control of pRb during precocious growth arrest.
The present results suggest that suppression of the Rb signaling pathway is required for immortalization of human myogenic cells in addition to telomere restoration (Figures 9Ba-f) . Either Bmi-1 (ref. 9) or wild-type CDK4 (ref. 13 ) was coexpressed with hTERT in primary cultured human myogenic cells to block the p16 INK4a signaling pathway, but the cells did not undergo immortalization. The results indicate that neither Bmi-1 nor the wild-type CDK4 alone allows hTERT to immortalize human myogenic cells, and that immortalization of human myogenic cells still requires secondary changes under these conditions. In fact, the combined expression of wild-type CDK4 and hTERT or Bmi-1 and hTERT results in immortalization of human myogenic cells exclusively under the optimized culture conditions supplemented with dexamethasone and growth factors, 13, 14 although the role of those supplements has been unknown. It is conceivable that CDK4 kinase activity released from the inhibition by p16 INK4a is not high enough to hyperphosphorylate Rb (Figures 9Bc and d) . In contrast, CDK4R24C allows hTERT to promote slow, but continuous, proliferation in primary cultured human myogenic cells (Figure 9Be) . CDK4R24C contributes to hyperphosphorylation of Rb, whereas the contribution of forced expression of wild-type CDK4 is quite limited because p16 INK4a inhibits the kinase activity of wild-type CDK4. Our previous study indicated that E7 prevents Rb independently of p16 INK4a and leads to immortalization of hTERT-expressing human myogenic cells 9 (Figure 9Bb) . Given that the suppression of Rb, but not p16 INK4a , is quite effective in immortalization of human myogenic cells, we concluded that complete inhibition of both Rb activation and telomere shortening is necessary and sufficient for immortalization of human myogenic cells.
Combined expression of CDK4R24C, cyclin D1 and hTERT successfully and reproducibly immortalized human myogenic cells derived from normal and disease muscles, resulting in rapid proliferation without compromising differentiation potential. Cyclin D1 has a crucial role as a limiting factor of CDK4 kinase activity. Forced expression of cyclin D1 increases CDK4R24C kinase activity to an extent that is relevant for hyperphosphorylation of Rb, which then results in rapid proliferation, possibly due to the potent inhibition of Rb function (Figure 9Bf ). The slower cycling of human myogenic cells immortalized by either E7 or CDK4R24C and hTERT also implies that higher CDK4 activity is required for rapid proliferation (Figures 9Bb  and e) . However, we cannot exclude a possibility that extraordinarily high activity of the CDK4R24C/cyclin D1 complex results in the phosphorylation of putative off-target substrates that have an essential role in the cell cycle progression and are usually phosphorylated by another member of the CDK family (Figure 9Bf ). Forced expression of CDK4R24C and cyclin D1 did not affect the differentiation potential of human myogenic cells, although forced expression of cyclin D1 alone inhibits myogenesis of the mouse myoblastic cell line C2C12. 31, 32 Rb was completely dephosphorylated during the differentiation culture, even though CDK4R24C and cyclin D1 still remained at high levels in the immortalized human myogenic cells. CDK inhibitors p21 cip1 and p27 kip1 are unlikely to be involved in the suppression of CDK4R24C activity during terminal muscle differentiation because the amount of the inhibitors does not increase in human myogenic cells (Shiomi and Hashimoto, unpublished data). Therefore, the present results imply another novel pathway leading to the suppression of CDK4/cyclin D1 activity at the post-translational level in human myogenic cells.
Immortalized human myogenic cells that preserve normal differentiation potential have been reported in two previous studies. 9, 13 However, the previously established human myogenic cell clones require 36-48 h for doubling, whereas primary cultured human myogenic cells divide every 20-30 h. In addition, one of them also required additional supplementation of the multifunctional steroid dexamethasone and hepatocyte growth factor, whose roles in immortalization process are unknown. 13 The other was established in our previous study with the use of oncogene product E7 for immortalization. 9 In contrast to previous ones, the present human myogenic cell clones retain a growth property similar to that of primary cultured human myogenic cells in the early passages, multipotentiality and normal diploid chromosomes. Therefore, the immortalized normal myogenic cells established in the present study are the human equivalent to mouse myogenic cell lines, and will contribute to fundamental and therapeutic studies.
The novel immortalization method established in the present study is more reliable and reproducible than the previously reported methods. We have succeeded in immortalization of several primary cultured human myogenic cells independently obtained from normal and diseased muscles including Duchenne muscular dystrophy and Fukuyama congenital muscular dystrophy (Hashimoto, unpublished data). Immortalized human myogenic cells from different neuromuscular diseases are currently being established in our laboratories and those of our collaborators. Human cell models of various neuromuscular diseases will contribute to causal analysis of symptoms and therapeutic approaches of rare diseases.
MATERIALS AND METHODS

Isolation and culture of human myogenic cells
The human myogenic cell clone Hu5 was isolated from normal subcutaneous muscle tissue of a 42-year-old woman, 4 and other human myogenic cells were obtained from normal abdominal muscle tissues of a 75-year-old man (Hu20, passage 2; A), a 50-year-old man (Hu21), a 69-year-old man (Hu23) and a 65-year-old man (Hu26). To prepare primary cultured human myogenic cells, muscle fragments were minced, digested with TrypLE Express (Invitrogen, Carlsbad, CA, USA) and then a small amount of cells obtained from 20-40 mg muscle were plated on a 90-mm dish coated with type I collagen (Sumilon, Tokyo, Japan). The cells were maintained at 371C under 10% CO 2 in dishes coated with type I collagen and containing primary cultured myocyte growth medium (pmGM) consisting of Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% fetal bovine serum (FBS), 2% Ultroser G (Biosepra, Cedex-Saint-Christophe, France) and glucose (4.5 mg ml À1 ). Cells were plated at 2Â10 5 per 90-mm dish and cultured in pmGM. For induction of myogenic differentiation, the medium was changed to primary cultured myocyte differentiation medium after 48 h of culture; it consists of the chemically defined medium TIS 33, 34 supplemented with 2% FBS.
For induction of terminal osteogenic differentiation, cells were cultured in DMEM supplemented with 10% FBS, glucose (4.5 mg ml À1 ) and 10 mM b-glycerophosphate (b-GP) (Sigma, St Louis, MO, USA) alone. The cells were Human myogenic cells recapture growth property K Shiomi et al stained with the calcium dye Alizarin Red S (2%, Sigma). 4 Images of stained dishes were obtained with a digital scanner (GT-9700F; Epson, Osaka, Japan) and then post-processed using Adobe Photoshop (Adobe Systems, San Jose, CA, USA). To induce adipogenic differentiation, we cultured myogenic cells in DMEM supplemented with 10% FBS, glucose (4.5 mg ml À1 ) and 100 mM g-linolenic acid (Sigma) for up to 5 days. The cells were stained with 0.3% Oil Red O (Sigma). 4 Figure 8 Multiclonal populations of primary cultured myogenic cells HM1 and HM2, which were originally registered as M06-736 and M07-635, were obtained from biceps brachii muscles of Leigh disease patients, who were 3-month-and 5-year-old males, at the National Center of Neurology and Psychiatry (Kodaira, Japan). The mortal clones HM1-8 and HM2-5 were isolated from HM1 and HM2, respectively, at the National Center for Geriatrics and Gerontology. HM1 and HM2 had been cultured at 371C under 5% CO 2 in non-coated standard tissue culture dishes containing DMEM/Ham's F12¼1:1 supplemented with 20% FBS and glucose (4.5 mg ml À1 ) alone, and cryopreserved at the National Center of Neurology and Psychiatry. The cells were cultured under the same conditions as Hu5 in the present study.
Viral vector construction and viral transduction
Lentiviral vector plasmids were constructed by recombination using the Gateway system (Invitrogen). Briefly, the EF1a promoter in CSII-EF-RfA (a gift from Dr H Miyoshi, RIKEN) was replaced with a tetracyclin-inducible promoter, TRE-Tight, from pTRE-Tight (Clontech, Mountain View, CA, USA) to generate CSII-TRE-Tight-RfA. Human cyclin D1 and human mutant CDK4 (CDK4R24C: an INK4a resistant form of CDK4, generously provided by Dr E Hara) were first recombined into entry vectors by a BP reaction (Invitrogen). Then these segments were recombined with CSII-TRE-Tight-RfA by an LR reaction (Invitrogen) to generate CSII-TRE-Tight-cyclin D1 and -CDK4R24C. The rtTA segment from pTet-Off Advanced (Clontech) was amplified by PCR and first recombined with the donor vector pDONR221 by BP reaction (Invitrogen) to generate pENTR221-TetOff, and then recombined with a lentiviral vector, CSII-CMV-RfA, by LR reaction (Invitrogen) to generate CSII-CMV-TetOff. Construction of CSII-CMV-cyclin D1, -CDK4R24C and -hTERT was described previously. 35 The recombinant lentiviruses with the vesicular stomatitis virus G glycoprotein were produced as described previously. 36 The recombinant retroviruses encoding hTERT and E7 were produced as described previously. 9, 37 Hu5, HM1-8 and HM2-5 cells were transduced with recombinant lentiviruses and retroviruses as described. 9, 11, 35 Following inoculation with viruses, the continuously proliferating cells were selected without drug treatment.
For single-cell cloning, transfected Hu5 cells were suspended at 5 cells per ml, and then 100 ml of the cell suspension was dispensed to each well of a 96-well plate coated with collagen, so that each well contained zero or one cell. Single-cell-derived clones were isolated and expanded for experimentation. The immortalized human myogenic cell clone KD3 will be available from RIKEN BioResorce Center (http://www.brc.riken.go.jp).
Analysis on growth properties
In total, 2000 cells were plated per well of a 12-well plate coated with type I collagen. Cells were collected and cell numbers were counted every 24 h between days 3 and 8 of culture in pmGM. Averages and s.d.'s of cell numbers per well from three independent wells were estimated.
To detect synthesizing DNA, cells were incubated with 10 mM 5-bromo-2¢-deoxyuridine (Sigma) for the last 6 h of each culture, fixed in paraformaldehyde for 10 min and then subjected to immunofluorescence analysis after denaturation of DNA with 2 M HCl and neutralization with 0.1 M Na 2 B 4 O 7 according to the manufacturer's instructions (Roche Diagnostics, Indianapolis, IN, USA).
Karyotyping
After incubation in pmGM supplemented with 2 mM colcemid at 371C for 6 h, cells were trypsinized and incubated in 0.5 ml of 1% sodium citrate for 15 min. This was followed by addition of 0.5 ml of Carnoy's fixative (methanol/acetic acid, 3:1 by volume). The fixed cells were then spun down and resuspended in 0.5 ml of Carnoy's fixative. Metaphase chromosomes were stained with 10% Giemsa solution (Wako Pure Chem., Osaka, Japan) for 10 min.
Immunobloting analysis
Sample preparation and immunoblot analysis were performed as previously described. 33, 34, 38 Immune complexes were detected by colorimetry with a BCIP/ NBT detection kit (Nacalai, Kyoto, Japan) or an ECL kit (GE Healthcare, Piscataway, NJ, USA). Primary antibodies included mouse monoclonal antibodies to chicken sarcomeric myosin heavy chain (MF20, undiluted culture supernatant), 39 p16 INK4a (BD Bioscience, Franklin Lakes, NJ, USA), p21 cip1 (Merk KGaA, Darmstadt, Germany), p53 (Merk), Rb (BD Bioscience), CDK2 (8A12, Medical Biological Laboratory, Nagoya, Japan), cyclin D1 (BD Bioscience) and b-tubulin (GE Healthcare), and a rabbit polyclonal antibody to CDK4 (Hashimoto, unpublished) . Secondary antibodies included alkaline phosphatase (DAKO, Carpinteria, CA, USA)-or horseradish peroxidase (GE Healthcare)-labeled antibodies to mouse or rabbit immunoglobulin G. Immune complexes on the PVDF membranes (Fluoro Trans W; Pall, Port Washington, NY, USA) were scanned with a digital scanner (GT-9700F; Epson) or LAS-4000 IR multicolor (Fujifilm, Tokyo, Japan) and then post-processed using Adobe Photoshop (Adobe Systems).
Transplantation of human myogenic cells
Immortalized human myogenic cells were labeled with modified Venus green fluorescent protein by transduction with a lentivirus vector, CSII-CMV-MCS-IRES2-Venus (kindly provided by Dr Miyoshi). Tibialis anterior (TA) muscles of 10-week-old female NOD/Scid mice were injected with 20 ml of 10mM cardiotoxin (Wako Pure Chem.). 40 On the next day, 1Â10 6 of the Venuslabeled cells suspended in 30 ml of L-15 (Sigma) were transplanted into the regenerating TA muscle. At 4 weeks after transplantation, the TA muscles were removed and quickly frozen in isopentane cooled with liquid nitrogen and processed for preparation of cryosections as described. 41 Muscle specimens were sectioned at a thickness of 7 mm with a cryostat.
Immunofluorescence analysis
The frozen sections and cultured cells were fixed with 4% paraformaldehyde at 41C for 30 or 10 min, respectively, and then incubated with primary antibodies. Primary antibodies included those to mouse monoclonal antibodies to mouse MyoD (5.8A, 1:10 dilution, Novocastra, Newcastle, UK), myosin heavy chain (undiluted supernatant), laminin a2 (1:100 dilution, Enzo Life Science, Farmingdale, NY, USA), 5-bromo-2¢-deoxyuridine (1:50 dilution, Roche Diagnostics) and rabbit polyclonal antibodies to green fluorescent protein (1:500 dilution, Medical Biological Laboratory) and Ki-67 (1:2 dilution, YLEM, Rome, Italy). Secondary antibodies were biotinylated Alexa 488 or Cy3-labeled antibodies to mouse, rat (Jackson ImmunoResearch Laboratory, Bar Harbor, ME, USA) or rabbit (Molecular Probes, Eugene, OR, USA). The biotinylated antibodies were detected with streptavidin-conjugated horseradish peroxidase. The peroxidase reaction was performed with 3,3-diaminobenzidine (Sigma). Cell nuclei were stained with 2,4-diamidino-2-phenylindole dihydrochloride n-hydrate (1.0 mg ml À1 , Sigma) or hematoxylin (Wako). Samples were visualized using an upright microscope (model BX50; Olympus, Tokyo, Japan) and a CCD camera (DP70; Olympus), or an inverted microscope (model IX71; Olympus) and a CCD camera (DP70; Olympus). Images were post-processed using Adobe Photoshop (Adobe Systems).
Suppression and induction of gene expression using Tet-Off system TKD1 cells (5Â10 4 cells per 35-mm dish) were cultured for 2 days in pmGM and then the medium was changed to pmGM supplemented with 250 nM doxycycline (Sigma). To remove doxycyline from the culture, the cells were replated twice and cultured in pmGM (Roche Diagnostics) according to the manufacturer's instructions.
